TCM
BSX icon

TimesSquare Capital Management’s Boston Scientific BSX Stock Holding History

TimesSquare Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,624,075
Closed -$76.5M – 246
2017
Q3 		$76.5M Sell
2,624,075
-146,125
-5% -$4.04M 0.51% 69
2017
Q2 		$76.8M Sell
2,770,200
-15,000
-0.5% -$398K 0.49% 70
2017
Q1 		$69.3M Sell
2,785,200
-262,400
-9% -$6.38M 0.45% 89
2016
Q4 		$65.9M Sell
3,047,600
-1,306,625
-30% -$28.5M 0.44% 91
2016
Q3 		$104M Sell
4,354,225
-176,725
-4% -$4.22M 0.67% 37
2016
Q2 		$106M Sell
4,530,950
-693,550
-13% -$15M 0.7% 33
2016
Q1 		$98.3M Sell
5,224,500
-125,200
-2% -$2.2M 0.64% 41
2015
Q4 		$98.6M Buy
5,349,700
+75,425
+1% +$1.35M 0.62% 43
2015
Q3 		$86.6M Sell
5,274,275
-12,025
-0.2% -$206K 0.54% 62
2015
Q2 		$93.6M Sell
5,286,300
-397,400
-7% -$7.1M 0.51% 70
2015
Q1 		$101M Sell
5,683,700
-378,500
-6% -$5.98M 0.54% 64
2014
Q4 		$80.3M Sell
6,062,200
-242,900
-4% -$3.11M 0.45% 85
2014
Q3 		$74.5M Sell
6,305,100
-96,500
-2% -$1.22M 0.42% 91
2014
Q2 		$81.7M Sell
6,401,600
-519,000
-7% -$6.75M 0.44% 80
2014
Q1 		$93.6M Sell
6,920,600
-461,200
-6% -$6.05M 0.49% 62
2013
Q4 		$88.7M Sell
7,381,800
-183,800
-2% -$2.17M 0.45% 73
2013
Q3 		$88.8M Sell
7,565,600
-161,300
-2% -$1.74M 0.5% 57
2013
Q2 		$71.6M Buy
+7,726,900
New +$65.5M 0.44% 74

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

TimesSquare Capital Management's BSX Position: Q4 2017 in Review

TimesSquare Capital Management sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 2,624,075 shares — an estimated $76.5M sold.

TimesSquare Capital Management first reported a position in BSX in Q2 2013 and held it in 18 quarters. The position peaked at $106M in Q2 2016. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • TimesSquare Capital Management reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • TimesSquare Capital Management sold 2,624,075 Boston Scientific shares in Q4 2017, an estimated $76.5M.
  • TimesSquare Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 18 quarters.
  • TimesSquare Capital Management's Boston Scientific position peaked at $106M in Q2 2016.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on TimesSquare Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.